Acme United (ACU) Q1 2025 earnings summary

Executive summary

• Net sales for Q1 2025 rose 2% year-over-year to $46 million, driven by strong first aid and medical product sales, partially offset by lower school and office product sales.

• Net income increased to $1.7 million from $1.6 million, with diluted EPS up 5% to $0.41.

• Operating income declined to $2.43 million from $2.56 million year-over-year, reflecting higher SG&A expenses.

• First-aid business grew 14% year-over-year, driving overall growth.

• Company is actively pursuing acquisitions and cost reduction initiatives, including automation and productivity improvements.

Financial highlights

• Gross margin improved to 39.0% from 38.7% year-over-year.

• SG&A expenses increased to $15.5 million (34% of sales), up from $14.8 million (33% of sales) in Q1 2024.

• Free cash flow of approximately $12 million generated over the past 12 months.

• Bank debt less cash was $27 million as of March 31, 2025, down from $32 million a year earlier.

• Cash and cash equivalents declined to $3.45 million from $6.40 million at year-end 2024.

Outlook and guidance

• No formal guidance issued due to tariff and cost base instability; price increases and productivity savings over $2 million are planned to offset rising costs.

• Management expects continued organic growth in first-aid (8%-12%) and moderate growth in cutting tools (2%-4%).

• Cash from operations and available credit expected to be sufficient for the next twelve months.

• Tariff uncertainty, inflation, and supply chain risks expected to impact pricing and demand.